AP3S1 Knockout HeLa Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population targeting the AP3S1 gene in HeLa cells, providing a loss-of-function model for the sigma-1 subunit of the adaptor protein complex 3 (AP-3). This polyclonal format avoids clonal selection artifacts and enables population-level analyses of lysosomal trafficking phenotypes, suitable for studies requiring interrogation of AP-3-dependent sorting mechanisms without additional gene editing.
The parental HeLa line is an HPV-18 positive cervical adenocarcinoma derived from a 31-year-old African American woman, valued for its robust growth, ease of transfection, and extensive characterization. Its epithelial origin and transformed state make it a relevant host for membrane trafficking studies in cancer biology, where HPV-18 oncoproteins may modulate endolysosomal dynamics and offer a context to examine AP3S1 function.
AP3S1 encodes the sigma-1 subunit of the heterotetrameric AP-3 complex, which sorts transmembrane proteins from the trans-Golgi network to lysosomes. AP-3 assembly requires AP3S1 together with AP3B1, AP3D1, and AP3M1, along with clathrin and ARF1, and is regulated by upstream kinases including mTORC1, PKA, and Src family kinases, with transcription driven by SP1 and NF-Y. Key cargoes include LAMP1, LAMP2, tyrosinase, and CD63. Disruption of AP3S1 impairs complex formation, leading to cargo mislocalization and perturbed interactions with motor proteins kinesin and dynein, and SNAREs VAMP7 and syntaxin 7, thereby disrupting lysosomal protein targeting, autophagy, and mTORC1-related signaling.
In HeLa cells, AP3S1 knockout provides a tractable model for dissecting lysosomal trafficking defects relevant to Hermansky-Pudlak syndrome and lysosomal storage disorders, enabling analysis of cargo mistrafficking, lysosomal enzyme secretion, and autophagic flux. The HPV-18 positive background may reveal cancer-specific vulnerabilities in lysosomal targeting, making this model versatile for both basic mechanistic studies and translational research.
These cells support immunofluorescence for LAMP1 localization, western blotting for AP-3 subunits, co-immunoprecipitation of complex components, and flow cytometry for surface CD63 to assess lysosomal exocytosis. RT-qPCR confirms gene disruption, while electron microscopy reveals ultrastructural changes. They are also suitable for screening AP-3 modulators or conducting RNAi rescue experiments. For further details, please contact Ascent Research.
